Identification and management of prediabetes

Results of the Latin America Strategic Prediabetes Meeting

Bibliographic Data

ID14966341
AuthorsPatricio López‐jaramillo (0000-0002-9122-8742, Foscal Hospital, corresponding author), Patricio Lopez-Jaramillo (Metabolic Syndrome and Diabetes Clinic, Fundación Oftalmológica de Santander, Bucaramanga, Santander, Colombia. Send correspondence to Patricio López-Jaramillo, [email protected]), Ramfis Nieto-Martínez (0000-0002-0575-7534), Ramfis E Nieto-Martínez (Human Physiology, Universidad Centro-Occidental Lisandro Alvarado, Barquisimeto, Venezuela.), Gestne Aure-Fariñez (Centro Medico Docente la Trinidad, Caracas, Venezuela.), Gestne Aure (0000-0002-1450-8863, Centro Médico Docente La Trinidad), Carlos O Mendivil (0000-0001-5546-4206, Universidad de los Andes, Bogotá, Colombia.), Rodolfo A Lahsen (Clínica Las Condes, Santiago, Chile.), Rodolfo Lahsen (Clínica Las Condes), Ruy L Silva-Filho (Federal University of Pernambuco, Recife, Brazil.), Luiz A Andreotti (Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Mónica E Manrique (Nutrition and Diabetes Unit, Clínica Alemana, Santiago, Chile.), Miguel A Pasquel-Andrade (Instituto VIDA, Quito, Ecuador.), Ignacio Rangel (0000-0003-3383-9219, Medical School, Monterrey Technological Institute, Monterrey, Mexico.), Maricela Vidrio (Research Cardiometabolic Unit, Occidente SC, Guadalajara, Mexico.), Rutila Castañeda (Center for Clinical Research, Mexico City, Mexico.), Manuela Restrepo (Merck Colombia, Bogotá, Colombia.), Manuela Lince Restrepo, Miguel E Pinto (School of Medicine Alberto Hurtado, Cayetano Heredia University, Lima, Perú.)
Year2017
Volume41
Pages1
Publication date2017-12-12
Open AccessYes
TypeARTICLE
VenueRevista Panamericana de Salud Pública (JOURNAL)
Journal identifiersISSN: 1020-4989 • E-ISSN: 1680-5348
PublisherPan American Health Organization (PUBLISHER • US)
DOI10.26633/rpsp.2017.172
PMID31410086
OpenAlexW2784321649
LanguageEN
References cited22

To understand the status of prediabetes diagnosis and treatment in Latin America and to evaluate the use of metformin for diabetes prevention in this context . A panel of 15 diabetes experts from seven countries in Latin America met on 14 – 15 August 2014 in Lima, Peru, to review the available literature, discuss the role of prediabetes in type 2 diabetes mellitus and cardiovascular disease, analyze collected information, and make conclusions for prediabetes diagnosis and treatment in Latin America . Prediabetes diagnosis, screening, and treatment, including lifestyle changes, pharmacological treatment, and cost-effectiveness were discussed. Five resulting statements were issued for Latin America: prediabetes is a clinical and public health problem; health care systems do not currently diagnose/treat prediabetes; use of prediabetes risk detection tools are needed region-wide; treatment includes lifestyle changes, multidisciplinary education, and metformin; and registries of patient records and further studies should be supported . The expert panel concluded that in Latin America, preventive treatment through lifestyle changes and metformin are cost-effective interventions. It is important to improve prediabetes identification and management at the primary care level

Context (archaeology · Diabetes mellitus · Geography · Impaired glucose tolerance · Latin Americans · Metformin · Political science · Prediabetes · Type 2 diabetes · Diabetes, Cardiovascular Risks, and Lipoproteins · Medicine · Metabolism, Diabetes, and Cancer · Natural Antidiabetic Agents Studies · Endocrinology · Gerontology

Tools

Open DOIOpen Access